DYXC Stock Overview
DiaSys Corporation designs, develops, manufactures, and distributes proprietary medical laboratory equipment, consumables, and test kits to healthcare and veterinary diagnostic laboratories worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
DiaSys Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0002 |
| 52 Week High | US$0.001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 19,900.00% |
| 3 Month Change | n/a |
| 1 Year Change | 19,900.00% |
| 3 Year Change | 100.00% |
| 5 Year Change | 19,900.00% |
| Change since IPO | -99.99% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| DYXC | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 19,900.0% | -4.1% | -3.7% |
| 1Y | 19,900.0% | -2.2% | 20.5% |
Return vs Industry: DYXC exceeded the US Medical Equipment industry which returned 2.2% over the past year.
Return vs Market: DYXC exceeded the US Market which returned 20.2% over the past year.
Price Volatility
| DYXC volatility | |
|---|---|
| DYXC Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: DYXC's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine DYXC's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | n/a | Frederic Neikrug | n/a |
DiaSys Corporation designs, develops, manufactures, and distributes proprietary medical laboratory equipment, consumables, and test kits to healthcare and veterinary diagnostic laboratories worldwide. The company was founded in 1992 and is based in Waterbury, Connecticut.
DiaSys Corporation Fundamentals Summary
| DYXC fundamental statistics | |
|---|---|
| Market cap | US$5.14k |
| Earnings (TTM) | -US$754.62k |
| Revenue (TTM) | US$1.59m |
0.0x
P/S Ratio0.0x
P/E RatioIs DYXC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DYXC income statement (TTM) | |
|---|---|
| Revenue | US$1.59m |
| Cost of Revenue | US$750.71k |
| Gross Profit | US$836.79k |
| Other Expenses | US$1.59m |
| Earnings | -US$754.62k |
Last Reported Earnings
Sep 30, 2007
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did DYXC perform over the long term?
See historical performance and comparison